Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | -2.30% | 0.00% | -36.34% |
13/05 | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
09/05 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.34% | 249M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Barclays Adjusts Price Target on Coherus BioSciences to $13 From $15, Maintains Overweight Rating